Home-Based Executive Function Training Intervention For Attention-Deficit/ Hyperactivity Disorder-prone Children

NCT ID: NCT06950866

Last Updated: 2025-04-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-01

Study Completion Date

2025-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to investigate the effectiveness of a home-based executive function training Intervention on children's ADHD symptoms, executive function and parents' parenting stress.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Attention Deficit Hyperactivity Disorder (ADHD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

Group Type EXPERIMENTAL

Home-based executive function training therapy

Intervention Type BEHAVIORAL

Parents receive a 2-week, 20-session online child executive function training program, delivered by a systematically trained and supervised therapist.

Waitlist group

Group Type OTHER

Home-based executive function training therapy

Intervention Type BEHAVIORAL

After the postintervention data collection, parents in the waitlist group receive a 2-week, 20-session online child executive function training program, delivered by a systematically trained and supervised therapist.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Home-based executive function training therapy

Parents receive a 2-week, 20-session online child executive function training program, delivered by a systematically trained and supervised therapist.

Intervention Type BEHAVIORAL

Home-based executive function training therapy

After the postintervention data collection, parents in the waitlist group receive a 2-week, 20-session online child executive function training program, delivered by a systematically trained and supervised therapist.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1.SNAP-IV scale, inattention or hyperactivity-impulsivity scale score \> 1.2
* 2.Parents who could understand or lacking of access to computers and the Internet
* 3.Parents can commit to ensuring full participation and complete the training and test evaluations in full compliance with the researcher's requirements
* 4.Children and their parents consent to the study

Exclusion Criteria

* 1.Children or parents with severe organic encephalopathy and other severe mental disorders
* 2.Parents or children are receiving ADHD-related behavioral treatment
* 3.Parents or children who dropped out before the study started or in the middle of the study
Minimum Eligible Age

6 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wuhan Mental Health Centre

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KY2024.0710.15

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.